Sarborg Limited raised funds at $125,000 per share, implying a $638.3 million valuation, to launch its SarborgQ quantum computing division and expand its AI-driven Signature Intelligence platform. CDT’s 1,020-share stake is now valued at $127.5 million, reflecting third-party validation of its strategic investment.
Sarborg completed a subscription at $125,000 per share, bringing its fully diluted valuation to approximately $638.3 million. Proceeds will finance the launch of SarborgQ, a new quantum computing division, while supporting expansion of proprietary datasets, intellectual property development, and enhancement of its AI platform.
CDT Equity holds 1,020 shares in Sarborg, whose latest per-share price implies a value of $127.5 million for CDT’s investment. This marks a significant uplift over prior valuations and quantifies CDT’s exposure to Sarborg’s growth.
The transaction serves as third-party validation of Sarborg’s Signature Intelligence business model and underscores the potential upside for CDT Equity. By aligning with SarborgQ’s quantum computing initiative, CDT strengthens its position in AI-driven biopharmaceutical development and asset repositioning strategies.
